Advertisement
Advanced Search
< Previous Article
Next Article >
January 2010Volume 28, Issue 1, Pages 95–102
Switch to Standard ViewSwitch to Enhanced View

Termination of drug-induced torsades de pointes with overdrive pacing

Nathan P. Charlton
x
Nathan P. Charlton
, MD
,
David T. Lawrence
x
David T. Lawrence
, DO
,
William J. Brady
x
William J. Brady
, MD
,
Mark A. Kirk
x
Mark A. Kirk
, MD
,
Christopher P. Holstege
x
Christopher P. Holstege
Search for articles by this author

Correspondence

  • Corresponding author. Division of Medical Toxicology, University of Virginia School of Medicine, PO Box 800774, Charlottesville, VA 22908-0774, USA. Fax: +1 434 971 8657.
, MDcorrespondence
x
Christopher P. Holstege
Search for articles by this author

Correspondence

  • Corresponding author. Division of Medical Toxicology, University of Virginia School of Medicine, PO Box 800774, Charlottesville, VA 22908-0774, USA. Fax: +1 434 971 8657.
Department of Emergency Medicine, University of Virginia School of Medicine, Charlottesville, VA 22908, USA
DOI: http://dx.doi.org/10.1016/j.ajem.2008.09.029

References

  1. [1]Viskin, S., Justo, D., Halkin, A., Zeltser, D. Long QT syndrome caused by noncardiac drugs. Prog Cardiovasc Dis. 2003;45:415–427.
  2. [2]Kao, L.W., Furbee, R.B. Drug-induced Q-T prolongation. Med Clin North Am. 2005;89:1125–1144.
  3. [3]Yap, Y.G., Camm, A.J. Drug induced QT prolongation and torsades de pointes. Heart. 2003;89:1363–1372.
  4. [4]Gowda, R.M., Khan, I.A., Wilbur, S.L., Vasavada, B.C., Sacchi, T.J. Torsade de pointes: the clinical considerations. Inter J Cardiol. 2004;96:1–6.
  5. [5]Liu, J., Laurita, K.R. The mechanism of pause-induced torsade de pointes in long QT syndrome. J Cardiovasc Electrophysiol. 2005;16:981–987.
  6. [6]Thomsen, M.B., Volders, P.G., Beekman, J.D., Matz, J., Vos, M.A. Beat-to-beat variability of repolarization determines proarrhythmic outcome in dogs susceptible to drug-induced torsades de pointes. J Amer Coll Cardiol. 2006;48:1268–1276.
  7. [7]Sadanaga, T., Sadanaga, F., Yao, H., Fujishima, M. An evaluation of ECG leads used to assess QT prolongation. Cardiol. 2006;105:149–154.
  8. [8]Gupta, A., Lawrence, A.T., Krishnan, K., Kavinsky, C.J., Trohman, R.G. Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes. Am Heart Jour. 2007;153:891–899.
  9. [9]Chan, A., Isbister, G.K., Kirkpatrick, C.M., Dufful, S.B. Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram. QJM. 2007;100:609–615.
  10. [10]Khan, I.A., Gowda, R.M. Novel therapeutics for treatment of long-QT syndrome and torsade de pointes. Int J Cardiol. 2004;95:1–6.
  11. [11]Chiang, C.E. Congenital and acquired long QT syndrome: current concepts and management. Cardiol Rev. 2004;12:222–234.
  12. [12]Viskin, S. Long QT syndromes and torsade de pointes. Lancet. 1999;354:1625–1633.
  13. [13]Mancuso, E.M., Brady, W.J., Harrigan, R.A., Pollack, M., Chan, T. Electrocardiographic manifestations: long QT Syndrome. J Emerg Med. 2004;27:385–393.
  14. [14]Roden, D.M. Cellular basis of drug-induced torsades de pointes. Br J Pharmacol. 2008;154:1502–1507.
  15. [15]Tzivoni, D., Keren, A., Cohen, A.M., Loebel, H., Zahavi, I., Chenzbraun, A. et al, Magnesium therapy for torsades de pointes. Am J of Cardiol. 1984;53:528–530.
  16. [16]Prielipp, R.C., Butterworth, J.F., Roberts, P.R., Black, K.W., Zaloga, G.P. Magnesium antagonizes the actions of lysophosphatidyl choline (LPC) in myocardial cells: a possible mechanism for its antiarrhythmic effects. Anesth Analg. 1995;80:1083–1087.
  17. [17]Iseri, L.T., Allen, B.J., Ginkel, M.L., Brodsky, M.A. Ionic biology and ionic medicine in cardiac arrhythmias with particular reference to magnesium. Am Heart J. 1992;123:1404–1409.
  18. [18]Tzivoni, D., Banai, S., Schuger, C., Benhorin, J., Keren, A., Gottlieb, S. et al, Treatment of torsade de pointes with magnesium sulfate. Circulation. 1988;77:392–397.
  19. [19]Anonymous. Part 12: pediatric advanced life support. Circulation. 2005;112:167–187.
    • [20]Hoshino, K., Ogawa, K., Hishitani, T., Isobe, T., Eto, Y. Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome. Pediatr Int. 2006;48:112–117.
    © 2010 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
    Access this article on
    ScienceDirect
    Visit ScienceDirect to see if you have access via your institution.

    Article Tools

    Related Articles

    Searching for related articles..

    Advertisement
    < Previous Article
    Next Article >
    January 2010Volume 28, Issue 1, Pages 95–102